EUVIMEDEUVIMED entdecken
Multizentrische Studie

Optimizing Unilateral Pelvic Lymph Node Dissection in the PSMA Era: Balancing Oncological Safety, Contralateral Involvement Risk, and Overtreatment in Prostate Cancer: A Multicenter Study of the Turkish Urooncology Association

Cagri Akpinar, Evren Suer, Nejdet Karsıyakalı, Nihat Karakoyunlu, Serhat Cetin, Güven Aslan, Deniz Bolat, Volkan Izol, Cenk Y Bilen, Sinan Sozen, Levent Turkeri, Sumer Baltaci

Clinical Genitourinary Cancer · 2025

DOI: 10.1016/j.clgc.2025.102432 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Genitourinary Cancer, 2025. Verfasst von Cagri Akpinar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, Ankara University, Ankara, Turkey. Electronic address: akpinarc@ankara.edu.tr. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Lymph Node Excision. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the risk of contralateral lymph node involvement (LNI) and the feasibility of safely performing unilateral pelvic lymph node dissection (PLND) in unfavorable-intermediate and high-risk prostate cancer (PCa) patients with cN0 status on preoperative 68Ga-PSMA PET/CT, tumor involvement in single lobe, or dominant lobe involvement with worse tumor characteristics on biopsy. MATERIAL AND METHODS: In this retrospective multicenter study were analyzed 768 patients who underwent RP and bilateral extended-PLND. Patients with cN0 status on PSMA PET/CT and PI-RADS ≥ 3 lesions on multiparametric magnetic resonance imaging(mpMRI) were included. Tumor lobe (single/dominant-prostatic lobe) involvement and LNI status were recorded for all patients. The dominant lobe was determined based on higher ISUP grade group(GG), number and percentage of more positive cores, and more advanced features on MRI, respectively. LNI status was analyzed by tumor side and location. Statistical analysis included univariate and multivariate models to evaluate predictors of contralateral LNI. RESULTS: LNI was observed in 96(12.5%) of 768 patients, with 61(7.9%) having ipsilateral LNI and 35(4.6%) contralateral LNI with or without ipsilateral LNI. Patients with contralateral LNI had higher preoperative PSA, more frequent EAU high-risk classification, larger-index lesion diameter, higher ISUP GG on both the dominant and nondominant side, and a higher rate of positive percentages in the nondominant side (all P values < .05). Multivariate analysis identified preoperative PSA (HR 1.028, 95% Cl 1.001-1.057, P = .044), ISUP GG 2 (HR 4.325,95% Cl-1.620-14.374,P = .007) and ≥ ISUP-GG 3 (HR 14.004, 95% Cl 3.025-54.773, P < .001) on the nondominant side as independent predictors for contralateral LNI. The ROC-derived AUC for predicting contralateral LNI was 0.873, indicating good predictive accuracy. CONCLUSION: In cases where preoperative 68Ga-PSMA PET/CT indicates a negative LN status, contralateral PLND may not be necessary in intermediate-risk patients with negative biopsy or ISUP GG 1 tumor on the nondominant side.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsLymph Node ExcisionHumansMaleRetrospective StudiesAgedMiddle AgedPositron Emission Tomography Computed TomographyPelvisLymphatic MetastasisTurkeyProstatectomyLymph NodesMedical OveruseGallium Isotopes

Stichwörter der Autor:innen

Lymph node involvementPSMA PET/CTRadical prostatectomyRisk stratificationSurgical decision-making

Substanzen

Gallium Isotopes

Autor:innen und Institutionen

  • Department of Urology, School of Medicine, Ankara University, Ankara, Turkey. Electronic address: akpinarc@ankara.edu.tr.
  • Department of Urology, School of Medicine, Ankara University, Ankara, Turkey.
  • Department of Urology, School of Medicine, Acıbadem University, Istanbul, Turkey.
  • Department of Urology, Ankara Etlik City Hospital, Ankara, Turkey.
  • Department of Urology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Department of Urolog, School of Medicine, Dokuz Eylul University, Izmir, Turkey.

Zitieren

APA

Akpinar, C., Suer, E., Karsıyakalı, N., Karakoyunlu, N., Cetin, S., Aslan, G., Bolat, D., Izol, V., Bilen, C. Y., Sozen, S., Turkeri, L., & Baltaci, S. (2025). Optimizing Unilateral Pelvic Lymph Node Dissection in the PSMA Era: Balancing Oncological Safety, Contralateral Involvement Risk, and Overtreatment in Prostate Cancer: A Multicenter Study of the Turkish Urooncology Association. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2025.102432

Vancouver

Akpinar C, Suer E, Karsıyakalı N, Karakoyunlu N, Cetin S, Aslan G, et al. Optimizing Unilateral Pelvic Lymph Node Dissection in the PSMA Era: Balancing Oncological Safety, Contralateral Involvement Risk, and Overtreatment in Prostate Cancer: A Multicenter Study of the Turkish Urooncology Association. Clinical Genitourinary Cancer. 2025. doi:10.1016/j.clgc.2025.102432

BibTeX
@article{Akpinar2025,
  author = {Akpinar, Cagri and Suer, Evren and Karsıyakalı, Nejdet and Karakoyunlu, Nihat and Cetin, Serhat and Aslan, Güven and Bolat, Deniz and Izol, Volkan and Bilen, Cenk Y and Sozen, Sinan and Turkeri, Levent and Baltaci, Sumer},
  title = {Optimizing Unilateral Pelvic Lymph Node Dissection in the PSMA Era: Balancing Oncological Safety, Contralateral Involvement Risk, and Overtreatment in Prostate Cancer: A Multicenter Study of the Turkish Urooncology Association},
  journal = {Clinical Genitourinary Cancer},
  year = {2025},
  doi = {10.1016/j.clgc.2025.102432}
}
Kostenlos starten →